. Author manuscript; available in PMC: 2010 Jul 1.

Published in final edited form as: Schizophr Res. 2009 May 2;112(1-3):65–71. doi: 10.1016/j.schres.2009.04.002

Table 1.

A summary of the demographic data for the subjects used in the study. Gender data is provided as the ratio of males (M) to females (F). Incidence of suicide data is provided as the number of subjects who committed suicide per sample size. All other data is provided as means ± the standard deviation. Antipsychotic mediation is listed as final prescribed dose of neuroleptic medication expressed as chlorpromazine equivalence per day.

	Short Duration of Illness		Long Duration of Illness

	Control	Schizophrenia	Control	Schizophrenia
Gender	12 M : 3 F	12 M : 3 F	12 M : 3 F	12 M : 3 F
Age	29.9±12.1 yr	29.4±12.5 yr	58.9±10.7 yr	58.2±11.0 yr
Post-mortem interval	47.3±11.8 hr	47.5±13.2 hr	37.1±16.9 hr	38.4 hr
CNS pH	6.30±0.21	6.29±0.15	6.35±0.18	6.33±0.17
RIN	8.0±1.0	7.8±1.4	7.26±1.7	7.7±1.0
Duration of illness		4.1±1.8 yr		33.7±9.3 yr
Incidence of suicide	0/15	11/15	0/15	1/15
Antipsychotic medication		732.85±780.74 mg		494.03±355.86mg